â??A Study to Evaluate the Efficacy of Shirobasti(Pulling of medicated oil) and Nasya(medicinal nasal drops) With and Without Medicine (Levodopa) in the Management of Kampavata (Parkinsonâ??s Disease).
Phase 2
Completed
- Conditions
- Health Condition 1: G20-G26- Extrapyramidal and movement disordersHealth Condition 2: G32- Other degenerative disorders of nervous system in diseases classified elsewhereHealth Condition 3: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhereHealth Condition 4: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhere
- Registration Number
- CTRI/2018/08/015533
- Lead Sponsor
- ational Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 27
Inclusion Criteria
1.Patients between 40-70 years of age.
2.Patients with clinical signs and symptoms of Kampavata/ PD.
3.Patients of either sex irrespective of their occupation, religion and socio-economic status.
4.Patients of kampavata/PD who are on a fixed dose of levodopa and fit for Shirobasti and Nasya.
5.Patients of kampavata/PD who are not on levodopa and fit for Shirobasti and Nasya.
6.Patients willing to participate for interventional study.
Exclusion Criteria
1.Patients with severe systemic disorders as Uncontrolled Hypertension, Cardiac Problem, Diabetes Mellitus, Tuberculosis, Leprosy, Paralysis, malignant disease etc.
2.Patients unfit for Shirobasti and Nasya.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method